US Slams Supplier’s Defense in Kickback Case
Executive Summary
The latest government filing in a False Claims Act case involving Coloplast counters the defendants’ argument that the case should be dismissed because the alleged kickbacks fell within the "discount" safe harbor.
You may also be interested in...
Medical Device-Makers Face Dynamic Commercial Compliance Risks
Erinn Hutchinson, a Philadelphia-based health industries risk consultant with PricewaterhouseCoopers LLP, talked to Medtech Insight about how she advises medical device companies – big and small – trying to market devices in a dynamic legal compliance environment.
Byram, Hollister To Pay $20M To Settle Pay-For-Promotion Allegations
The settlement puts to bed whistleblower allegations that Hollister paid supplier Byram for encouraging ostomy and continence care patients to use Hollister products. Byram allegedly had similar arrangements with other manufacturers, including Coloplast.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.